- HTG Molecular Diagnostics Inc Key Opinion Leader (KOL) “The Role of RNA Profiling in Drug Discovery and Analysis” - Corporate Call TranscriptDec 13, 2022
- Q2 2022 HTG Molecular Diagnostics Inc Earnings Call TranscriptAug 11, 2022€13.06 (+0.93%)Earnings
- HTG Molecular Diagnostics Inc Host a Key Opinion Leader (KOL) Webinar TranscriptJul 27, 2022
- Q1 2022 HTG Molecular Diagnostics Inc Earnings Call TranscriptMay 12, 2022€6.54 (-20.84%)Earnings
- Q4 2021 HTG Molecular Diagnostics Inc Earnings Call TranscriptMar 29, 2022€17.16Earnings
- Q3 2021 HTG Molecular Diagnostics Inc Earnings Call TranscriptNov 10, 2021€51.12 (-1.84%)Earnings
- Q2 2021 HTG Molecular Diagnostics Inc Earnings Call TranscriptAug 12, 2021€59.04 (-4.47%)Earnings
- Q1 2021 HTG Molecular Diagnostics Inc Earnings Call TranscriptMay 13, 2021€36.72 (-6.13%)Earnings
- Q4 2020 HTG Molecular Diagnostics Inc Earnings Call TranscriptMar 25, 2021€54.24 (-2.16%)Earnings
- Q3 2020 HTG Molecular Diagnostics Inc Earnings Call TranscriptNov 10, 2020€53.28 (+8.82%)Earnings
- Q2 2020 HTG Molecular Diagnostics Inc Earnings Call TranscriptAug 11, 2020€95.4 (+2.91%)Earnings
- Q1 2020 HTG Molecular Diagnostics Inc Earnings Call TranscriptMay 13, 2020€64.44 (+0.56%)Earnings
- Q4 2019 HTG Molecular Diagnostics Inc Earnings Call TranscriptMar 25, 2020€53.28 (-1.99%)Earnings
- HTG Molecular Diagnostics, Inc. - Special Call TranscriptDec 13, 2019
- Q3 2019 HTG Molecular Diagnostics Inc Earnings Call TranscriptNov 12, 2019€126 (-3.45%)Earnings
- HTG Molecular Diagnostics, Inc. - Special Call TranscriptOct 29, 2019
- Q2 2019 HTG Molecular Diagnostics Inc Earnings Call TranscriptAug 06, 2019€209.88 (+1.99%)Earnings
- Q1 2019 HTG Molecular Diagnostics Inc Earnings Call TranscriptMay 09, 2019€388.89 (-0.78%)Earnings
- Q4 2018 HTG Molecular Diagnostics Inc Earnings Call TranscriptMar 07, 2019€405 (+0.90%)Earnings
Q4 2018 HTG Molecular Diagnostics Inc Earnings Call Transcript
Greetings, and welcome to the HTG Molecular Diagnostics Fourth Quarter and Full Year 2018 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I'd now like to turn the conference over to your host, Monique Kosse. Thank you. You may begin.
(technical difficulty)
HTG released financial results for the fourth quarter and year ended December 31, 2018.
Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including statements regarding the company's performance trends, growth of its RUO profiling business, activities expected to occur under the company's various collaborations and other agreements, planned product developments and launches and related expected benefits, expected benefits from pharma collaborations and revenue and operating expense expectations for 2019.
These forward-looking statements are subject to numerous risks and uncertainties,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)